Pfizer and Ranbaxy settle Lipitor patent dispute

NEW YORK - Pfizer Inc. and India's Ranbaxy Laboratories Ltd. said Wednesday they have settled their patent dispute over the blockbuster cholesterol drug Lipitor, delaying the release of generic versions in the United States until Nov. 30, 2011....More